• AGO1 Regulates Stem Cell Fate via Protein Folding, Not Small

  2026-04-30

  Liu et al. (2024) reveal that AGO1, unlike AGO2, maintains pluripotency in mouse embryonic stem cells through a novel RNA-independent mechanism involving protein folding. This discovery refines our understanding of stem cell fate decisions and presents new avenues for manipulating self-renewal and differentiation in stem cell research.

• Optimizing Cancer Research with LEE011 Succinate: Protocols

  2026-04-30

  Ribociclib succinate (LEE011 succinate) stands as a gold-standard CDK inhibitor for HER2-positive metastatic breast cancer research, enabling precise cell cycle regulation and robust antineoplastic assays. This guide delivers actionable workflows, evidence-based troubleshooting, and protocol enhancements, ensuring researchers maximize reproducibility and translational impact.

• GGFG Peptide: Redefining Bioconjugation in Oncology Research

  2026-04-29

  This article explores the mechanistic and translational significance of Gly-Gly-Phe-Gly (GGFG) as a flexible peptide linker, highlighting how recent discoveries in multiple myeloma—specifically panobinostat-induced calcineurin (PPP3CA) degradation—open new avenues for antibody-drug conjugate engineering. Drawing from the latest peer-reviewed evidence and positioning APExBIO’s high-purity GGFG peptide at the forefront, the article provides actionable guidance for researchers aiming to optimize drug conjugation strategies in oncology.

• Harnessing Ionomycin Calcium Salt in Translational Oncology

  2026-04-29

  This thought-leadership article explores how ionomycin calcium salt, a potent calcium ionophore, empowers translational researchers to interrogate calcium signaling in cancer progression and therapy. By integrating mechanistic insights—especially from recent discoveries on the STIM1-Ca2+ axis in metastasis—this piece provides strategic guidance for leveraging APExBIO’s ionomycin calcium salt in experimental and preclinical workflows, with a focus on apoptosis, modulation of Bcl-2/Bax ratio, and workflow reproducibility.

• Validating Metabolite Regulation of TET2: Protocol and Insig

  2026-04-28

  Zhang et al. present a robust protocol integrating biochemical assays and STD NMR spectroscopy to validate metabolite binding and regulation of human TET2 dioxygenase. This framework advances the study of metabolic-epigenetic interplay, enabling systematic identification of TET2 activators and inhibitors with clear implications for cancer epigenetics.

• Baicalin Methyl Ester: Applied Workflows for Intestinal Barr

  2026-04-28

  Baicalin methyl ester, an esterified derivative of baicalin, enables precision modulation of intestinal barrier function and inflammation in both in vitro and in vivo models. This article unpacks real-world protocols, troubleshooting strategies, and comparative insights—empowering researchers to advance gut barrier protection with rigor and reproducibility.

• Medroxyprogesterone Acetate: Optimizing Decidualization Rese

  2026-04-27

  Medroxyprogesterone acetate (MPA) is redefining experimental workflows in reproductive and renal biology with robust, reproducible results. This article details actionable protocols, troubleshooting strategies, and the latest ACSL4-decidualization insights, empowering researchers to leverage APExBIO’s MPA for advanced translational studies.

• Streptavidin – Cy5: Reliable Biotin Detection in Cell Assays

  2026-04-27

  This article addresses real laboratory challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how Streptavidin – Cy5 (SKU K1080) provides reproducible, sensitive biotin detection. Readers gain evidence-based workflow guidance, quantitative context, and scenario-driven answers to vendor selection, compatibility, and data interpretation—all grounded in validated best practices for modern biomedical research.

• Deoxynivalenol-Induced Liver Injury: Mitophagy and Nrf2 Disr

  2026-04-26

  This study reveals that deoxynivalenol (DON), a widespread mycotoxin, induces liver injury by overactivating PINK1/Parkin-mediated mitophagy and suppressing the p62-Keap1-Nrf2 cytoprotective pathway. The findings clarify a dual mechanism of mitochondrial dysfunction and impaired antioxidant defense, providing a mechanistic basis for future hepatotoxicity research and intervention design.

• Saracatinib (AZD0530): Applied Workflows in Cancer and Synap

  2026-04-25

  Saracatinib (AZD0530) is a dual Src/Abl kinase inhibitor that empowers high-fidelity research in cancer cell proliferation, migration, and synaptic signaling. This guide delivers practical protocols, troubleshooting strategies, and cross-domain applications, drawing on landmark studies and APExBIO’s trusted quality.

• Budesonide for Respiratory Disease Research: Applied Workflo

  2026-04-24

  Harness Budesonide’s potent anti-inflammatory corticosteroid activity for robust asthma and airway inflammation models. This article delivers evidence-backed workflow enhancements, practical troubleshooting, and key insights from the latest chromatographic permeability modeling—enabling researchers to maximize reproducibility and assay sensitivity using APExBIO’s high-purity Budesonide.

• Applied Workflows with Doxorubicin Hydrochloride in Cancer R

  2026-04-24

  Unlock the full experimental potential of Doxorubicin hydrochloride with advanced protocol design, validated troubleshooting, and translational insight. Leverage evidence-backed workflows to model cancer cytotoxicity and cardiotoxicity with precision and reproducibility.

• Nanobody Targeting PstS-1: A Molecular Imaging Advance in TB

  2026-04-23

  Dhekale et al. (2025) report the isolation of a high-affinity nanobody (C8Nb) specific for the Mycobacterium tuberculosis PstS-1 protein, demonstrating its targeted binding in TB granulomas. This approach highlights a promising platform for molecular imaging-based TB diagnostics, especially where conventional methods are insensitive.

• Applied Firefly Luciferase mRNA: From 5-moUTP to Assay Preci

  2026-04-23

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) delivers robust, immune-silent reporter expression—ideal for mRNA delivery, translation efficiency assays, and in vivo imaging. This guide walks through optimized workflows, troubleshooting, and how recent advances in delivery chemistry can further elevate your assay outcomes.

• SU5416 (Semaxanib): Translational Insights From Angiogenesis

  2026-04-22

  Explore the unique translational value of SU5416 (Semaxanib) as a VEGFR2 inhibitor in advanced cancer and pulmonary arterial hypertension research. This deep dive integrates mechanistic insights and recent biomarker discoveries to inform cutting-edge experimental design.

16621 records 1/1109 page Next 12345 下5页 Last page